Prostate cancer hijacks biorhythm of tumor cell to bypass hormone therapy

Prostate cancer hijacks biorhythm of tumor cell to bypass hormone therapy

Hormone therapy can keep metastatic prostate cancer well under control, but sooner or later tumor cells become resistant to it. Unexpectedly, a